title: Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.
abstract: No therapeutics or vaccines currently exist for human coronaviruses (HCoVs). The Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV) epidemic in 2002-2003, and the recent emergence of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in April 2012, emphasize the high probability of future zoonotic HCoV emergence causing severe and lethal human disease. Additionally, the resistance of SARS-CoV to ribavirin (RBV) demonstrates the need to define new targets for inhibition of CoV replication. CoVs express a 3'-to-5' exoribonuclease in nonstructural protein 14 (nsp14-ExoN) that is required for high-fidelity replication and is conserved across the CoV family. All genetic and biochemical data support the hypothesis that nsp14-ExoN has an RNA proofreading function. Thus, we hypothesized that ExoN is responsible for CoV resistance to RNA mutagens. We demonstrate that while wild-type (ExoN+) CoVs were resistant to RBV and 5-fluorouracil (5-FU), CoVs lacking ExoN activity (ExoN-) were up to 300-fold more sensitive. While the primary antiviral activity of RBV against CoVs was not mutagenesis, ExoN- CoVs treated with 5-FU demonstrated both enhanced sensitivity during multi-cycle replication, as well as decreased specific infectivity, consistent with 5-FU functioning as a mutagen. Comparison of full-genome next-generation sequencing of 5-FU treated SARS-CoV populations revealed a 16-fold increase in the number of mutations within the ExoN- population as compared to ExoN+. Ninety percent of these mutations represented A:G and U:C transitions, consistent with 5-FU incorporation during RNA synthesis. Together our results constitute direct evidence that CoV ExoN activity provides a critical proofreading function during virus replication. Furthermore, these studies identify ExoN as the first viral protein distinct from the RdRp that determines the sensitivity of RNA viruses to mutagens. Finally, our results show the importance of ExoN as a target for inhibition, and suggest that small-molecule inhibitors of ExoN activity could be potential pan-CoV therapeutics in combination with RBV or RNA mutagens.
authors: Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
authors: Everett Clinton
authors: EC
authors: Smith
authors: Hervé
authors: H
authors: Blanc
authors: Matthew C
authors: MC
authors: Surdel
authors: Marco
authors: M
authors: Vignuzzi
authors: Mark R
authors: MR
authors: Denison
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D001254:Astrocytoma / Q000188:drug therapy / Q000378:metabolism / Q000821:virology; D001932:Brain Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000821:virology; D049109:Cell Proliferation / Q000187:drug effects; D017934:Coronavirus / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics*; D018352:Coronavirus Infections / Q000188:drug therapy / Q000235:genetics* / Q000821:virology; D005095:Exoribonucleases / Q000235:genetics / Q000378:metabolism*; D016679:Genome, Viral; D006801:Humans; D051379:Mice; D016296:Mutagenesis / Q000235:genetics*; D009153:Mutagens / Q000494:pharmacology; D009154:Mutation / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D012367:RNA, Viral / Q000235:genetics* / Q000378:metabolism; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D009153:Mutagens; D012333:RNA, Messenger; D012367:RNA, Viral; D014764:Viral Proteins; D005095:Exoribonucleases
references: PLoS Med. 2006 Sep;3(9):e343
references: 16968120
references: Mol Gen Genet. 1994 Feb;242(3):289-96
references: 8107676
references: Pharmacotherapy. 2007 Apr;27(4):494-503
references: 17381375
references: J Biol Chem. 2003 Oct 31;278(44):43770-80
references: 12882968
references: JAMA. 2001 Jan 10;285(2):193-9
references: 11176813
references: Nature. 1969 Aug 23;223(5208):848-50
references: 5799033
references: Nucleic Acids Res. 2001 Mar 1;29(5):1017-26
references: 11222749
references: Emerg Infect Dis. 2009 Sep;15(9):1377-84
references: 19788804
references: PLoS Pathog. 2005 Oct;1(2):e11
references: 16220146
references: N Engl J Med. 1998 Nov 19;339(21):1493-9
references: 9819447
references: J Virol. 2012 Mar;86(5):2869-73
references: 22190724
references: Bioinformatics. 2009 Jul 15;25(14):1754-60
references: 19451168
references: N Engl J Med. 2003 May 15;348(20):1953-66
references: 12690092
references: J Biol Chem. 2001 Jun 29;276(26):23616-23
references: 11319228
references: Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7289-94
references: 12754380
references: J Biol Chem. 2013 Feb 22;288(8):5572-80
references: 23283971
references: J Virol. 2009 May;83(9):4538-47
references: 19244331
references: J Biol Chem. 2001 Nov 2;276(44):40847-57
references: 11526116
references: Emerg Infect Dis. 2008 Apr;14(4):626-31
references: 18400147
references: Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):E2294-303
references: 22853955
references: PLoS Pathog. 2010 May 06;6(5):e1000896
references: 20463816
references: Adv Exp Med Biol. 2006;581:61-6
references: 17037505
references: PLoS Pathog. 2012;8(11):e1003030
references: 23166498
references: J Virol. 2002 Nov;76(21):11065-78
references: 12368349
references: Nature. 2006 Jan 19;439(7074):344-8
references: 16327776
references: J Virol. 2012 Dec;86(23):12816-25
references: 22993147
references: N Engl J Med. 2012 Nov 8;367(19):1814-20
references: 23075143
references: Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2417-21
references: 2006180
references: RNA Biol. 2011 Mar-Apr;8(2):270-9
references: 21593585
references: N Engl J Med. 2003 May 15;348(20):1967-76
references: 12690091
references: J Biol Chem. 2001 Dec 7;276(49):46094-8
references: 11602568
references: J Virol. 2007 Jun;81(12):6356-68
references: 17392363
references: Nature. 2013 Mar 14;495(7440):251-4
references: 23486063
references: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5108-13
references: 16549795
references: J Virol. 2007 Nov;81(22):12135-44
references: 17804504
references: J Biol Chem. 1996 Aug 9;271(32):19428-35
references: 8702631
references: Virology. 1989 Jun;170(2):385-91
references: 2728344
references: PLoS One. 2010 Jun 22;5(6):e11265
references: 20582319
references: Nat Med. 2008 Feb;14(2):154-61
references: 18246077
references: Chest. 2005 Jul;128(1):263-72
references: 16002945
references: Science. 1972 Aug 25;177(4050):705-6
references: 4340949
references: J Virol. 2007 Apr;81(8):4012-20
references: 17267506
references: Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22505-10
references: 21148772
references: Virus Res. 2006 Apr;117(1):17-37
references: 16503362
references: Biochemistry. 2003 Dec 23;42(50):14711-9
references: 14674745
references: PLoS One. 2012;7(3):e32550
references: 22442668
references: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000
references: 14569023
references: Curr Opin Virol. 2012 Oct;2(5):519-24
references: 22857992
references: Microbiol Mol Biol Rev. 2012 Jun;76(2):159-216
references: 22688811
references: J Virol. 2007 Feb;81(4):2012-24
references: 17151116
references: J Virol. 2013 Apr;87(7):3741-51
references: 23325689
references: mBio. 2012 Nov 20;3(6):
references: 23170002
references: PLoS Pathog. 2010 Aug 26;6(8):e1001072
references: 20865120
references: J Biol Chem. 1993 Dec 25;268(36):27286-90
references: 7903306
references: Nat Rev Microbiol. 2009 Jun;7(6):439-50
references: 19430490
references: Euro Surveill. 2012 Oct 04;17(40):20290
references: 23078800
references: Nat Med. 2000 Dec;6(12):1375-9
references: 11100123
references: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3484-9
references: 19208801
references: Virus Res. 2005 Feb;107(2):207-14
references: 15649566
references: PLoS Pathog. 2010 Apr 22;6(4):e1000863
references: 20421945
references: J Mol Med (Berl). 2002 Feb;80(2):86-95
references: 11907645
references: Antiviral Res. 2006 Aug;71(1):53-63
references: 16621037
references: Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16038-43
references: 21896755
references: Nat Rev Drug Discov. 2007 Dec;6(12):991-1000
references: 18049473
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Lancet. 2003 Jun 14;361(9374):2045-6
references: 12814717
references: Virology. 1991 Apr;181(2):490-9
references: 1826574
references: Nat Med. 2012 Dec;18(12):1820-6
references: 23142821
references: J Biol Chem. 2005 Aug 19;280(33):29980-7
references: 15964835
references: J Virol. 2008 Dec;82(24):12346-55
references: 18829745
references: Antimicrob Agents Chemother. 2002 Apr;46(4):977-81
references: 11897578
references: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12938-43
references: 12215495
references: J Mol Biol. 2008 Oct 10;382(3):652-66
references: 18662697
references: Bioinformatics. 2009 Aug 15;25(16):2078-9
references: 19505943
references: Future Med Chem. 2009 Jun;1(3):529-39
references: 21426129
references: JAMA. 1983 May 20;249(19):2666-70
references: 6341640
references: Antiviral Res. 1998 Aug;39(2):63-79
references: 9806484
references: J Biol Chem. 2005 Jul 8;280(27):25706-16
references: 15878882
references: J Mol Biol. 2000 Jun 2;299(2):405-19
references: 10860748
references: Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6895-900
references: 11371613
references: Proc Natl Acad Sci U S A. 1973 Apr;70(4):1174-8
references: 4197928
references: Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9372-7
references: 22635272
references: Curr Opin Virol. 2011 Nov;1(5):419-22
references: 22440845
references: J Gen Virol. 2006 Jul;87(Pt 7):1947-1952
references: 16760396
references: Lancet. 2003 Apr 19;361(9366):1319-25
references: 12711465
references: J Virol. 2013 Jun;87(11):6296-305
references: 23536667
references: J Mol Biol. 2007 Mar 9;366(5):1459-74
references: 17223130
references: N Engl J Med. 1986 Jan 2;314(1):20-6
references: 3940312
references: Biochem J. 1969 Jul;113(3):515-24
references: 5807210